Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression

被引：0

作者：

Thase, Michael E. ^{[1
]}

机构：

[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA

[2] Western Psychiat Inst & Clin, Pittsburgh, PA 15261 USA

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 2006年 / 67卷 / 04期

关键词：

D O I：

暂无

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：671 / 672

页数：2

共 50 条

[1] Transdermal selegiline - A novel MAOI formulation for depression
Howland, Robert H.
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2006, 44 (07) : 9 - 12
[2] The effect of high dose orally disintegrated tablet selegiline, a selective monoamine oxidase B inhibitor (MAO-B), on monoamine oxidase A (MAO-A), and compared to transdermal formulation of selegiline
Fahn, S.
McCall-Perez, F.
Hammond, J.
Telang, F.
Logan, J.
Want, G-J.
Fowler, J.
MOVEMENT DISORDERS, 2011, 26 : S279 - S280
[3] Transdermal selegiline: The new generation of monoamine oxidase inhibitors
Patkar, Ashwin A.
Pae, Chi-Un
Masand, Prakash S.
CNS SPECTRUMS, 2006, 11 (05) : 363 - 375
[4] Selegiline and other atypical monoamine oxidase inhibitors in depression
Bodkin, JA
Kwon, AE
PSYCHIATRIC ANNALS, 2001, 31 (06) : 385 - 391
[5] Comparison of effectiveness and side effects of selegiline transdermal system versus oral monoamine oxidase inhibitors and tricyclic antidepressants for treatment-resistant depression
Kim, Thomas T.
Xu, Colin
Amsterdam, Jay D.
JOURNAL OF AFFECTIVE DISORDERS, 2025, 376 : 47 - 51
[6] The Effect of High Dose Orally Disintegrated Tablet Selegiline (ODT-S: Zelapar®), a Selective Monoamine Oxidase B Inhibitor (MAO-B), on Menoamine Oxidase A (MAO-A), and Compared to EMSAM® (Transdermal Formulation of Selegiline)
Fahn, Stanley
McCall-Perez, Fred
Hammond, Janet
Telang, Frank
Logan, Jean
Wang, Gene-Jack
Fowler, Joanna
NEUROLOGY, 2011, 76 (09) : A275 - A275
[7] TREATMENT OF TRICYCLIC REFRACTORY DEPRESSION WITH A MONOAMINE-OXIDASE INHIBITOR ANTIDEPRESSANT
MCGRATH, PJ
STEWART, JW
HARRISON, W
QUITKIN, FM
PSYCHOPHARMACOLOGY BULLETIN, 1987, 23 (01) : 169 - 172
[8] Monoamine Oxidase Inhibitor Use in an Adult Patient With Treatment Resistant Depression
Shora, Lorie
Zarate, Carlos
Park, Lawrence
Afanador, Melbaliz Velez
BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S304 - S304
[9] Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans
Heinonen, EH
Anttila, MI
Karnani, HL
Nyman, LM
Vuorinen, JA
Pyykko, KA
Lammintausta, RAS
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (07): : 602 - 609
[10] FOCUS ON SELEGILINE - A SELECTIVE MONOAMINE-OXIDASE TYPE-B INHIBITOR
KANDO, JC
KALUNIAN, DA
HOSPITAL FORMULARY, 1990, 25 (08): : 849 - &

← 1 2 3 4 5 →